Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004145733 | SCV003617144 | uncertain significance | not specified | 2022-05-11 | criteria provided, single submitter | clinical testing | The c.1250G>C (p.R417P) alteration is located in exon 2 (coding exon 1) of the B3GALT2 gene. This alteration results from a G to C substitution at nucleotide position 1250, causing the arginine (R) at amino acid position 417 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |